VHFC partner, Corgenix Medical Corporation, has developed the first commercialized diagnostic test that enables rapid diagnosis of Lassa viral hemorrhagic fever.
“This 15-minute test has the potential to completely change stye way Lassa fever is detected and treated,” said Douglas Simpson, Corgenix President.
Read the full press release on the Corgenix website.